Andrew Witty

21 results

Tesaro brings to GSK a marketed product for ovarian cancer, Zejula, which belongs to a promising new class of medicines.  Photograph: Toby Melville/Reuters

GlaxoSmithKline has agreed to buy US cancer specialist Tesaro for $5.1 billion (€4.5 billion), marking a major biotech investment by chief executive E(...)

GlaxoSmithKline building in Hounslow, west London: GSK, one of Britain’s two Big Pharma firms, decided to abandon plans for a new manufacturing plant in Ulverston in Cumbria. Photograph: Luke MacGregor GlaxoSmithKline building in Hounslow, west London: GSK, one of Britain’s two Big Pharma firms, decided to abandon plans for a new manufacturing plant in Ulverston in Cumbria. Photograph: Luke MacGregor

In a week when the UK’s Eurosceptic international trade minister Liam Fox suggested the British economy could easily manage without a trade deal with (...)

Emma Walmsley will be paid an annual base salary of about £1 million

Emma Walmsley, poised to take over as the first female chief executive of GlaxoSmithKline, will earn about a quarter less than her predecessor Andrew (...)

 GlaxoSmithKline. Photograph: Getty

GlaxoSmithKline has revealed a boost to annual earnings from the Brexit-hit pound but warned over a potential hit from looming competition to its bloc(...)

 GlaxoSmithKline:  says  sales of its meningitis vaccine   Bexsero  doubled in the third quarter, forcing the company to race to bring new manufacturing capacity online Photograph:  Warren Little/Getty Images

GlaxoSmithKline has taken a patent infringement action against Pfizer Ireland Pharmaceuticals and Pfizer Inc over a meningococcal group B vaccine. The(...)

Emma Walmsley: she will join the board on January 1st, and take the helm of the company on March 31st

GlaxoSmithKline promoted Emma Walmsley to be the new chief executive officer of the UK’s largest drugmaker, succeeding Andrew Witty when he retires. (...)

GSK plans to increase production of next-generation respiratory drugs and biotech medicines.

GlaxoSmithKline plans £275 million of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite (...)

Improving margins and growing demand for new drugs lifted GlaxoSmithKline’s underlying earnings a better-than-expected 14 per cent in the first quart(...)

Traders on the floor of the New York Stock Exchange:  Wall Street edged up early on Thursday as FedEx and GE shares lifted the industrials sector. Photograph: Lucas Jackson/Reuters

European equities ended lower yesterday, dragged down by exporters as the euro strengthened against the dollar after the US Federal Reserve flagged fe(...)

GlaxoSmithKline chief executive Andrew Witty pledges improve profits.

GlaxoSmithKline chief executive Andrew Witty asked investors to give him three years to improve profitability at the biggest UK pharmaceutical company(...)

  • 1
  • 2
  • 3
  • Next
  • Last »